ISDA

Deposition Date 2005-02-10

Release Date 2005-04-12

Last Version Date 2024-02-14

Entry Detail

PDB ID:

1YT9

Keywords:

HYDROLASE

Title:

HIV Protease with oximinoarylsulfonamide bound

Biological Source:

Source Organism:

Human immunodeficiency virus 1 (Taxon ID: 11676)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

3.00 Å

R-Value Free:

0.33

R-Value Work:

0.24

Space Group:

P 21 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Pol polyprotein
Chain IDs:A, B
Chain Length:99
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1

UniProt ID:P03366 Pfam ID:PF00077

Ligand Molecules

OIS

Primary Citation

Oximinoarylsulfonamides as potent HIV protease inhibitors.

Yeung, C.M, Klein, L.L, Flentge, C.A, Randolph, J.T, Zhao, C, Sun, M, Dekhtyar, T, Stoll, V.S, Kempf, D.J.Show

Bioorg.Med.Chem.Lett. 15 2275 2278 (2005)

PMID: 15837308 DOI: 10.1016/j.bmcl.2005.03.008

Abstact

The need for a potent HIV protease inhibitor (PI) to combat emerging PI-resistant viruses is anticipated. Analogs formulated from the combination of structural fragments of Ritonavir, Lopinavir, and Amprenavir were synthesized. Analogs containing the oxime pharmacophore were found to have improved activities against both wild type and resistant (A17) viruses. The synthesis and structure-activity relationships (SAR) based upon the in vitro IC50 of this series of compounds are reported.

Legend

Protein

Chemical

Disease

Primary Citation of related structures